Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Ipsen SA
ISIN FR0010259150
|WKN A0ESMG
Market cap (in EUR)
13,863 m
Country
France
Sector
Healthcare
Dividend yield
0.85%
Overview
Quote
Description
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals France
Chart
Financials
Key metrics
| Market capitalisation, EUR | 13,863 m |
| EPS, EUR | - |
| P/B ratio | 3.2 |
| P/E ratio | 30.8 |
| Dividend yield | 0.85% |
Income statement (2025)
| Revenue, EUR | 3,676 m |
| Net income, EUR | 444 m |
| Profit margin | 12.07% |
What ETF is Ipsen SA in?
There are 57 ETFs which contain Ipsen SA. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ipsen SA is the Amundi S&P Eurozone Dividend Aristocrat Screened UCITS ETF Dist.
Rendement
Aperçu des rendements
| Année en cours | +35,74% |
| 1 mois | +3,83% |
| 3 mois | +18,49% |
| 6 mois | +33,35% |
| 1 an | +62,70% |
| 3 ans | +47,82% |
| 5 ans | +102,02% |
| Depuis la création (MAX) | +111,42% |
| 2025 | +8,65% |
| 2024 | +2,08% |
| 2023 | +6,92% |
| 2022 | +24,94% |
Rendements mensuels dans une heat map
Risque
Les rendements des ETF comprennent les paiements de dividendes (le cas échéant).
Aperçu des risques
| Volatilité 1 an | 25,13% |
| Volatilité 3 ans | 24,71% |
| Volatilité 5 ans | 27,31% |
| Rendement par risque 1 an | 2,49 |
| Rendement par risque 3 ans | 0,56 |
| Rendement par risque 5 ans | 0,55 |
| Perte maximale sur 1 an | -11,78% |
| Perte maximale sur 3 ans | -29,88% |
| Perte maximale sur 5 ans | -31,93% |
| Perte maximale depuis la création | -31,93% |
Volatilité sur 1 an
Articles les plus récents
Articles les plus consultés
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.